Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SCG101 |
Synonyms | |
Therapy Description |
SCG101 comprises CD4- and CD8-positive autologous T-lymphocytes engineered to express a T-cell receptor targeting HBsAg, which potentially induce cytotoxicity against tumor cells and enhance antitumor immune activity (Journal for ImmunoTherapy of Cancer 2022;10). |